Skip to main content

Private Advisor Group, LLC

Source: SEC Form 13F · as of Mar 2026

Private Advisor Group, LLC holds 39 biotech & pharma companies tracked by BioSniper, totaling $54.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

39

Total value held

$54.4M

BioSniper AIPage context preserved

Prepared research question

What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
REGNREGENERON PHARMACEUTICALS, INC.17,315$13.4M
IBRXImmunityBio, Inc.1,648,556$12.6M
GILDGILEAD SCIENCES, INC.50,035$7.0M
SNYSanofi97,010$4.7M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)51,606$2.8M
TLXTelix Pharmaceuticals Limited174,415$1.7M
AVXLANAVEX LIFE SCIENCES CORP.499,700$1.5M
RVMDREVOLUTION MEDICINES, INC.9,967$969K
ARWRARROWHEAD PHARMACEUTICALS, INC.15,426$967K
ROIVRoivant Sciences Ltd.28,164$780K
ARGXARGENX SE1,066$778K
INSMINSMED Inc4,749$777K
TEVATeva Pharmaceutical Industries Limited21,888$659K
GERNGERON CORP423,328$631K
ADPTAdaptive Biotechnologies Corp43,977$610K
HUMAHumacyte Inc.832,799$505K
JAZZJazz Pharmaceuticals plc2,571$486K
TVTXTravere Therapeutics, Inc.15,422$458K
MRNAModerna, Inc.6,812$346K
DRTSAlpha Tau Medical Ltd.47,583$336K
IMMXImmix Biopharma, Inc.34,725$316K
MANEVeradermics Incorporated5,000$316K
VKTXViking Therapeutics, Inc.8,251$268K
SPRYARS Pharmaceuticals, Inc.30,242$243K
CNTACentessa Pharmaceuticals plc6,000$238K
CTMXCytomX Therapeutics, Inc.44,002$207K
RXRXRECURSION PHARMACEUTICALS, INC.66,839$205K
OCULOCULAR THERAPEUTIX, INC15,688$133K
ESPREsperion Therapeutics, Inc.38,606$106K
SLSSELLAS Life Sciences Group, Inc.19,540$83K
ZNTLZentalis Pharmaceuticals, Inc.31,472$74K
OPKOPKO HEALTH, INC.55,301$63K
ANTXAN2 Therapeutics, Inc.12,500$43K
LCTXLineage Cell Therapeutics, Inc.20,029$32K
ANIXAnixa Biosciences Inc10,221$26K
IMUXIMMUNIC, INC.10,000$11K
GELSGelteq Ltd16,668$11K
SGMOQSANGAMO THERAPEUTICS, INC28,000$7K
SCNXScienture Holdings, Inc.15,002$4K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.